Brief: Genscript Biotech Sees $505.2 Mln To $589.4 Mln In Revenue For HY

Genscript Biotech

26/07/2024 14:10

July 26 (Reuters) - Genscript Biotech Corp  1548.HK :
    * SEES US$505.2 MILLION TO US$589.4 MILLION IN REVENUE FOR
HY
    * SEES NARROWED NET LOSS OF US$212.9 MILLION TO US$225.9
MILLION
FOR HY
    * EXPECTED NET LOSS DUE TO INCREASED EXPENDITURES ON
RESEARCH AND
DEVELOPMENT ACTIVITIES, AMONG OTHERS


Further company coverage:  1548.HK 

 ((Reuters.Briefs@thomsonreuters.com;))